Lilly offers up to $1B for Alzheimer's drug; Bial cuts failed Parkinson's drug

June 9, 2026 10:37 AM EDT News Briefing Lil­ly of­fers up to $1B for Alzheimer's drug; Bial cuts failed Parkin­son's drug ENDPOINTS Plus news about Para­bilis Med­i­cines, RA Cap­i­tal, Tan­go Ther­a­peu­tics, Ideaya Bio­sciences, Bavar­i­an Nordic and Carte­sian Ther­a­peu­tics 💸 Lil­ly’s $1B Alzheimer’s deal: The In­di­anapo­lis drug­mak­er will … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER